| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.13 | 2e-05 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.14 | 8e-05 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0008 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0009 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.002 |